INTCO MEDICAL(SZ:300677) Sou Hu Cai Jing·2025-11-06 12:06Core Insights - The stock of Yingke Medical (300677) closed at 38.56 yuan on November 6, 2025, down 1.51% with a turnover rate of 2.19% and a trading volume of 101,900 hands, resulting in a transaction value of 393 million yuan [1] - The net outflow of main funds was 26.21 million yuan, accounting for 6.67% of the total transaction value, while retail investors saw a net inflow of 33.84 million yuan, representing 8.61% of the total transaction value [1][2] Financial Performance - For the first three quarters of 2025, Yingke Medical reported a main revenue of 7.425 billion yuan, an increase of 4.6% year-on-year, and a net profit attributable to shareholders of 924 million yuan, up 34.47% year-on-year [3] - The third quarter of 2025 saw a single-quarter main revenue of 2.511 billion yuan, a decrease of 2.9% year-on-year, while the single-quarter net profit attributable to shareholders was 214 million yuan, an increase of 113.04% year-on-year [3] - The company’s gross profit margin stood at 23.7%, with a net profit margin of 12.82% [3] Market Position - Yingke Medical has a total market capitalization of 25.249 billion yuan, ranking 9th in the medical device industry, with a net asset value of 18.467 billion yuan, ranking 4th [3] - The company’s price-to-earnings ratio (P/E) is 20.49, significantly lower than the industry average of 62.24, indicating a favorable valuation [3] - The company’s return on equity (ROE) is 5.19%, which is considerably higher than the industry average of 0.15% [3] Investment Sentiment - Over the last 90 days, five institutions have given a buy rating for Yingke Medical, indicating positive sentiment among analysts [4]